COOKIE POLICY Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy. MREO: US$2.06 ABOUT US PIPELINE PARTNERS INVESTORS NEWS AND EVENTS CONTACT US COVID-19 Information: View the Mereo BioPharma COVID-19 information page here Working together to inspire, innovate and improve lives SEE OUR LATEST NEWS News 9 Nov 2021 Mereo BioPharma to Present at Two Upcoming Investor Conferences 4 Nov 2021 Mereo Announces Data From Investigator-Sponsored Trial of Alvelestat In BOS 26 Oct 2021 Mereo Receives U.S. Orphan Drug Designation for alvelestat in Treatment of AATD PRESS RELEASES 29 NOV 2021 Mereo to Participate in Pre-Recorded Fireside Chat at Piper Sandler Annual Virtual Healthcare Conference: Available on Demand from 30 November, 2021 VIEW EVENT Meet the Team 22 NOV 2021 OUR LEADERSHIP We continue to make strong progress in development of our product portfolio, in the hope of providing better treatment options for patients with life limiting oncology and rare diseases Denise Scots-Knight, CEO OUR MISSION Subscribe to our email alerts SUBSCRIBE Privacy Policy Cookie Policy Terms and Conditions Sitemap Urgent Medical Inquiries and Expanded Access Careers Mereo BioPharma Group plc © 2021